A 60-kD protein mediates the binding of transforming growth factor-beta to cell surface and extracellular matrix proteoglycans

The biological activity of many cytokines is regulated by binding proteins present at the cell surface, in extracellular matrices or in soluble phase. We describe here a TGF-beta binding protein that is both an extracellular matrix and a cell surface protein. When intact extracellular matrices of HEP-G2 cells were affinity cross-linked with 125I-TGF-beta 1, two major binding components were seen: a 250-kD, proteoglycan-like molecule, presumed to be betaglycan, and a 60-kD protein. The 60-kD TGF-beta-binding protein was also present at the cell surface. It could be released from the cell surface by treating cells with high salt, heparin, chondroitin sulfate, heparitinase, or chondroitinase, indicating that it is bound to heparan sulfate and chondroitin sulfate proteoglycans. The 60-kD protein bound TGF-beta 1 with an apparent dissociation constant of 1.6 nM, and there were 30,000 binding sites per cell at the cell surface. In addition to the HEP-G2 cells and another hepatoma cell line, the 60-kD protein was also found in a human colon carcinoma (HT-29) cell line but not in rat kidney (NRK- 49F) or human fibroblast (HUT-12) cell lines. The 60-kD protein could be extracted from cells containing it and transferred to the surface of previously negative cells. The 60-kD protein may serve to regulate the binding of TGF-beta to its signal transducing receptors by targeting TGF-beta to appropriate locations in the microenvironment of cells.

[1]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[2]  L. Kedes,et al.  Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools , 1987, Molecular and cellular biology.

[3]  Marikki LaihoSQ,et al.  Transforming Growth Factor + Induction of Type-1 Plasminogen Activator Inhibitor , 2022 .

[4]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[5]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[6]  S. Schultz-Cherry,et al.  Transforming growth factor-beta complexes with thrombospondin. , 1992, Molecular biology of the cell.

[7]  E. Ruoslahti Structure and biology of proteoglycans. , 1988, Annual review of cell biology.

[8]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[10]  J. Massagué,et al.  Cell adhesion protein receptors as targets for transforming growth factor-β action , 1987, Cell.

[11]  D. Mcclure,et al.  Fibronectin‐associated transforming growth factor , 1987, Journal of cellular physiology.

[12]  T. McCaffrey,et al.  Transforming growth factor‐β1 is a heparin‐binding protein: Identification of putative heparin‐binding regions and isolation of heparins with varying affinity for TGF‐β1 , 1992 .

[13]  M. O’Connor-McCourt,et al.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.

[14]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[15]  R. Weinberg,et al.  Expression cloning and characterization of the TGF-β type III receptor , 1991, Cell.

[16]  W. Vale,et al.  The Inhibin/Activin Family of Hormones and Growth Factors , 1990 .

[17]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[18]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[19]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Massagué,et al.  Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta , 1989, The Journal of cell biology.

[21]  S. Vukicevic,et al.  Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development. , 1991, Developmental biology.

[22]  M. Sporn,et al.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Shigeki,et al.  Tenascin: cDNA cloning and induction by TGF‐beta. , 1988, The EMBO journal.

[24]  L. Zardi,et al.  Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. , 1988, FEBS letters.

[25]  A. Bassols,et al.  Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. , 1988, The Journal of biological chemistry.

[26]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[27]  K. Williams,et al.  2 – Enzymatic Digestion of Proteins and HPLC Peptide Isolation , 1993 .

[28]  M. Geisow A practical guide to protein and peptide purification for microsequencing , 1990 .

[29]  M. Sporn,et al.  Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. , 1983, Science.

[30]  J. Massagué,et al.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.

[31]  M. Sporn,et al.  Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes , 1989, The Journal of cell biology.

[32]  D. Selkoe,et al.  Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease. , 1990, Biochemical and biophysical research communications.

[33]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[34]  N. Ling,et al.  A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin. , 1988, The Journal of biological chemistry.

[35]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[36]  N. Tuross,et al.  Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. , 1987, The Journal of biological chemistry.

[37]  H. Moses,et al.  Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. , 1986, Cancer research.

[38]  K. Flanders,et al.  Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1. , 1992, Developmental biology.

[39]  A. Brunner,et al.  Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells , 1987, Molecular and cellular biology.

[40]  M. Sporn,et al.  Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. , 1989, The Journal of biological chemistry.

[41]  K. Titani,et al.  Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. , 1991, The Journal of biological chemistry.